Based on these observations, expert panels agreed that low PR expression can be used as a prognostic determinant for Luminal-like tumors (4), recommending its use in combination with others pathological factors such as Ki67, histological grade and tumor stage (4, 6). This evidence concerns the gene PGR and neoplasm.